197 related articles for article (PubMed ID: 20729922)
1. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.
McClune BL; Polgreen LE; Burmeister LA; Blaes AH; Mulrooney DA; Burns LJ; Majhail NS
Bone Marrow Transplant; 2011 Jan; 46(1):1-9. PubMed ID: 20729922
[TBL] [Abstract][Full Text] [Related]
2. Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.
Yao S; Smiley SL; West K; Lamonica D; Battiwalla M; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1130-7. PubMed ID: 20188201
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
Välimäki MJ; Kinnunen K; Volin L; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Ruutu T
Bone Marrow Transplant; 1999 Feb; 23(4):355-61. PubMed ID: 10100579
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
[TBL] [Abstract][Full Text] [Related]
7. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study.
Schulte C; Beelen DW; Schaefer UW; Mann K
Osteoporos Int; 2000; 11(4):344-53. PubMed ID: 10928225
[TBL] [Abstract][Full Text] [Related]
8. Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantation.
Hari P; DeFor TE; Vesole DH; Bredeson CN; Burns LJ
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1361-7. PubMed ID: 23806773
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation.
D'Souza AB; Grigg AP; Szer J; Ebeling PR
Intern Med J; 2006 Sep; 36(9):600-3. PubMed ID: 16911552
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy.
Yao S; McCarthy PL; Dunford LM; Roy DM; Brown K; Paplham P; Syta M; Lamonica D; Smiley S; Battiwalla M; Padmanabhan S; Hahn T
Bone Marrow Transplant; 2008 Feb; 41(4):393-8. PubMed ID: 17994116
[TBL] [Abstract][Full Text] [Related]
11. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
[TBL] [Abstract][Full Text] [Related]
12. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
13. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years.
Haugeberg G; Ørstavik RE; Uhlig T; Falch JA; Halse JI; Kvien TK
Arthritis Rheum; 2002 Jul; 46(7):1720-8. PubMed ID: 12124854
[TBL] [Abstract][Full Text] [Related]
14. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
Sahin G; Yasar NS; Sirmagul B; Bal C; Yalcin AU
Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
16. Bone loss and avascular necrosis of bone after hematopoietic cell transplantation.
McClune B; Majhail NS; Flowers ME
Semin Hematol; 2012 Jan; 49(1):59-65. PubMed ID: 22221785
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation.
McAvoy S; Baker KS; Mulrooney D; Blaes A; Arora M; Burns LJ; Majhail NS
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1231-6. PubMed ID: 20302963
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
[TBL] [Abstract][Full Text] [Related]
19. [Glucocorticoids and osteoporosis].
Zikán V
Vnitr Lek; 2007; 53(7-8):831-40. PubMed ID: 17915428
[TBL] [Abstract][Full Text] [Related]
20. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
Lange U; Teichmann J; Müller-Ladner U; Strunk J
Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
